Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Imuvert can prevent some chemotherapy-induced hair loss.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Plant-based medicines can effectively prevent and treat cancer with fewer side effects.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Chemotherapy targets all dividing cells, causing side effects like nausea and hair loss.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

New molecules can prevent cell death in hair follicles.

Some drugs can cause hair loss and skin issues.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

Medicinal plants have potential as alternative cancer treatments due to their ability to target and kill cancer cells.

Cancer treatments often cause skin, nail, and hair problems.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Proper management of skin and hair side effects from chemotherapy improves patients' quality of life.